Omnicell Reports Results for Fiscal Year and Fourth Quarter 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Omnicell (OMCL) PT Raised to $70 at Piper Jaffray
February 8, 2019 8:50 AM ESTPiper Jaffray analyst Sean Wieland raised the price target on Omnicell (NASDAQ: OMCL) to $70.00 (from $59.00) while maintaining a Neutral rating.
... MoreOmnicell (OMCL) Tops Q4 EPS by 3c, Revenues Miss; Offers Q1 & FY19 EPS Mid-Point Guidance Above Consensus, Q1 Revenues Guidance Below Consensus, FY19 Revenue Outlook Tops Views
February 7, 2019 4:36 PM ESTOmnicell (NASDAQ: OMCL) reported Q4 EPS of $0.70, $0.03 better than the analyst estimate of $0.67. Revenue for the quarter came in at $211.8 million versus the consensus estimate of $215.4 million.
"With the launch of our Autonomous Pharmacy vision at ASHP Midyear, health system pharmacists are... More
